Background: Delivery of therapeutic agents directly through the round window (RW) offers promise for treating sensorineural hearing loss. However, hearing loss can result from the surgical approach itself, and the reasons for this are poorly understood. We examined the hearing loss following the 3 major steps involved with the RW approach to access the mouse cochlea: bullostomy, RW puncture, and RW injection. Methods: Twenty-one adult CBA/J mice underwent bullostomy alone, 10 underwent RW puncture, and 8 underwent RW injection with PBS with 5% glycerol. Auditory brainstem responses (ABR) and otoscopy were performed preoperatively and up to 6 weeks postoperatively. Hair cells were stained, and survival was assessed using immunofluorescence. Results: One week postoperatively, mice in all groups showed significant threshold shifts. Otoscopy revealed approximately half of all mice had middle ear effusion (MEE), with a higher incidence of effusion in the RW puncture and RW injection groups. Those with MEE had significant ABR threshold shifts, whereas those without MEE had minimal hearing loss. MEE persisted through 6 weeks in a majority of cases, but in those mice with MEE resolution, there was at least partial improvement in hearing. Immunohistochemistry showed minimal loss of hair cells in all animals. Conclusion: MEE is highly correlated with hearing loss in mice undergoing RW surgery. Otoscopy is an important adjunct to consider after ear surgery in mice, as MEE may contribute to postsurgical hearing loss.

Keywords:
Ear surgery, Hearing loss, Inner ear, Middle ear, Round window membrane, Gene therapy
1.
Akil O, Rouse SL, Chan DK, Lustig LR: Surgical method for virally mediated gene delivery to the mouse inner ear through the round window membrane. J Vis Exp 2015;97:e52187.
2.
Akil O, Seal RP, Burke K, Wang C, Alemi A, During M, Edwards RH, Lustig LR: Restoration of hearing in the VGLUT3 knockout mouse using virally mediated gene therapy. Neuron 2012;75:283-293.
3.
Askew C, Rochat C, Pan B, Asai Y, Ahmed H, Child E, Schneider BL, Aebischer P, Holt JR: TMC gene therapy restores auditory function in deaf mice. Sci Transl Med 2015;7:295ra108.
4.
Chang Q, Wang J, Li Q, Kim Y, Zhou B, Wang Y, Li H, Lin X: Virally mediated Kcnq1 gene replacement therapy in the immature scala media restores hearing in a mouse model of human Jervell and Lange-Nielsen deafness syndrome. EMBO Mol Med 2015;7:1077-1086.
5.
Chien WW, McDougald DS, Roy S, Fitzgerald TS, Cunningham LL: Cochlear gene transfer mediated by adeno-associated virus: comparison of two surgical approaches. Laryngoscope 2015;125:2557-2564.
6.
Geleoc GS, Holt JR: Sound strategies for hearing restoration. Science 2014;344:1241062.
7.
Kawamoto K, Oh SH, Kanzaki S, Brown N, Raphael Y: The functional and structural outcome of inner ear gene transfer via the vestibular and cochlear fluids in mice. Mol Ther 2001;4:575-585.
8.
Kerschner JE, Hong W, Taylor SR, Kerschner JA, Khampang P, Wrege KC, North PE: A novel model of spontaneous otitis media with effusion (OME) in the Oxgr1 knock-out mouse. Int J Pediatr Otorhinolaryngol 2013;77:79-84.
9.
Kraft S, Hsu C, Brough DE, Staecker H: Atoh1 induces auditory hair cell recovery in mice after ototoxic injury. Laryngoscope 2013;123:992-999.
10.
MacArthur CJ, Hefeneider SH, Kempton JB, Trune DR: C3H/HeJ mouse model for spontaneous chronic otitis media. Laryngoscope 2006;116:1071-1079.
11.
Muller U, Barr-Gillespie PG: New treatment options for hearing loss. Nat Rev Drug Discov 2015;14:346-365.
12.
Okada H, Iizuka T, Mochizuki H, Nihira T, Kamiya K, Inoshita A, Kasagi H, Kasai M, Ikeda K: Gene transfer targeting mouse vestibule using adenovirus and adeno-associated virus vectors. Otol Neurotol 2012;33:655-659.
13.
Plassmann W, Kadel M: Low-frequency sensitivity in a gerbilline rodent, Pachyuromys duprasi. Brain Behav Evol 1991;38:115-126.
14.
Praetorius M, Baker K, Weich CM, Plinkert PK, Staecker H: Hearing preservation after inner ear gene therapy: the effect of vector and surgical approach. ORL J Otorhinolaryngol Relat Spec 2003;65:211-214.
15.
Qin Z, Wood M, Rosowski JJ: Measurement of conductive hearing loss in mice. Hear Res 2010;263:93-103.
16.
Steel KP, Moorjani P, Bock GR: Mixed conductive and sensorineural hearing loss in LP/J mice. Hear Res 1987;28:227-236.
17.
Stover T, Yagi M, Raphael Y: Cochlear gene transfer: round window versus cochleostomy inoculation. Hear Res 1999;136:124-130.
18.
Thorne M, Salt AN, DeMott JE, Henson MM, Henson OW Jr, Gewalt SL: Cochlear fluid space dimensions for six species derived from reconstructions of three-dimensional magnetic resonance images. Laryngoscope 1999;109:1661-1668.
19.
Wenzel GI, Xia A, Funk E, Evans MB, Palmer DJ, Ng P, Pereira FA, Oghalai JS: Helper-dependent adenovirus-mediated gene transfer into the adult mouse cochlea. Otol Neurotol 2007;28:1100-1108.
20.
Xia L, Yin S, Wang J: Inner ear gene transfection in neonatal mice using adeno-associated viral vector: a comparison of two approaches. PLoS One 2012;7:e43218.
21.
Yamasoba T, Yagi M, Roessler BJ, Miller JM, Raphael Y: Inner ear transgene expression after adenoviral vector inoculation in the endolymphatic sac. Hum Gene Ther 1999;10:769-774.
22.
Zheng QY, Tong YC, Alagramam KN, Yu H: Tympanometry assessment of 61 inbred strains of mice. Hear Res 2007;231:23-31.
© 2017 S. Karger AG, Basel
2017
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.